ETP Tablet contains Eltrombopag Olamine 50 mg, an oral thrombopoietin receptor agonist used to increase platelet production in patients with low platelet counts (thrombocytopenia). It is commonly prescribed in conditions where the body does not produce enough platelets or when platelet levels are reduced due to disease or treatment.

Eltrombopag helps stimulate the bone marrow to produce more platelets, thereby reducing the risk of bleeding and improving overall blood clotting function.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Uses

ETP Tablet 50 mg is indicated for:

• Chronic immune (idiopathic) thrombocytopenic purpura (ITP)
• Severe aplastic anemia (SAA)
• Thrombocytopenia associated with chronic liver disease (pre-procedural use)
• Low platelet count due to bone marrow failure (as advised by physician)
• Patients requiring improvement in platelet counts before surgery or procedures

Mechanism of Action

Eltrombopag works by stimulating platelet production:

• Activates thrombopoietin (TPO) receptors on bone marrow cells
• Promotes proliferation and differentiation of megakaryocytes
• Increases production of platelets in the bloodstream
• Helps reduce bleeding risk in thrombocytopenic patients

This action helps restore and maintain safer platelet levels in eligible patients.

Dosage & Administration

• Usual dose: 50 mg once daily or as prescribed by a physician
• Should be taken on an empty stomach (1 hour before or 2 hours after meals)
• Avoid taking with dairy products, calcium-rich foods, or antacids close to dosing time
• Dose adjustment may be required based on platelet response
• Regular blood count monitoring is essential during therapy

Side Effects

Common side effects may include:

• Nausea
• Headache
• Fatigue
• Liver enzyme elevation
• Muscle or joint pain
• Diarrhea

Serious but rare effects may include liver toxicity or thromboembolic events.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Use only under specialist supervision
• Monitor liver function regularly during treatment
• Not recommended in patients with severe hepatic impairment without adjustment
• Risk of excessive platelet increase (thrombosis) if not monitored
• Avoid use during pregnancy and breastfeeding unless clearly necessary
• Inform physician about all current medications and supplements

Storage

• Store below 25°C in a cool and dry place
• Protect from moisture and light
• Keep in original packaging
• Keep out of reach of children.